Biological activity of 3-formylchromones and related compound by 河瀬, 雅美 et al.
Abstract. Several 3-formylchromone derivatives were
examined for their tumor cell-cytotoxic, anti-Helicobacter
pylori, urease inhibitory and anti-HIV activity. Comparing their
relative cytotoxicity against four human tumor cell lines and
three normal human cells, tumor cell-specific cytotoxicity was
detected in some 3-formylchromone derivatives. There was no
clear-cut relationship between the cytotoxicity and the chemical
structures of the compounds. 6,8-Dichloro-3-formylchromone
(FC10) showed comparable anti-H. pylori activity with
metronidazole and potent urease inhibition against jack bean
urease. On the other hand, 6,8-dibromo-3-formylchromone
(FC11) exhibited potent inhibitory activity against the urease,
but had no anti-H. pylori activity. No chromones (FC1-16)
exhibited anti-HIV activity. 
The chromones (4H-1-benzopyran-4-ones) have attracted
attention from the point of view of both biological activity
(1, 2) and organic synthesis (2, 3). Chromone derivatives
have been found to exhibit a broad range of biological
activities, including antifungal, antiviral, antimicrobial,
antiallergenic, antitubulin and antitumor activity (1, 4). In
addition, many flavonoids are based on the chromone
structure and have been found to possess several
therapeutically interesting biological activities (5).
In our previous studies on the structure-cytotoxic
activity relationship with a series of ‚-diketones in human
tumor cells, 3-formylchromone (FC1) was shown to
exhibit potent cytotoxic activities against some tumor
cells and had tumor cell-specific cytotoxicity (6). The
presence of a formyl group at the C-3 position of the
chromone seems to be responsible for such biological
activity, because compound FC1 possesses an ·,‚-
unsaturated reactive aldehyde which can react as Michael
acceptors. It is known that 3-formylchromone derivatives
show induction of the chloroplast-free mutants in Euglena
gracilis (7), have antiproliferative activity (8), and act as
p56lck tyrosine kinase inhibitors (9) and modifiers of
multidrug resistance in mouse lymphoma cells and human
Colo320 colon cancer cells (10). It is also reported that
some 3-formylchromone derivatives showed a relatively
strong anti-anaphylactic reaction but generally had a low
LD50 (11). 
In the present study, we describe the effects produced by
3-formylchromones substituted at the C-6 position. We
evaluated their cytotoxicity against human tumor cell lines
and normal cells, and their anti-Helicobacter pylori (H.
pylori), urease inhibitory and anti-HIV activity; the
structurally related coumarine (2H-1-benzopyran-2-one)
derivatives were also investigated.
Materials and Methods
Chemicals. 3-Formylchromone (FC1) (MW=174), 3-formyl-6-
methylchromone (FC2) (MW=188), 3-formyl-6-isopropylchromone
(FC3) (MW=216), 3-formyl-6-nitrochromone (FC5) (MW=219), 6-
chloro-3-formylchromone (FC7) (MW=208.5), 6-bromo-3-
formylchromone (FC8) (MW=253), 6-chloro-3-formyl-7-methylchro-
mone (FC9) (MW=222.5), 6,8-dichloro-3-formylchro-mone (FC10)
(MW=243), 6,8-dibromo-3-formylchromone (FC11) (MW=332), 3-
cyanochromone (FC12) (MW=171), chromone (FC13) (MW=146),
3-acetylcoumarin (FC14) (MW=188), coumarin-3-carboxylic acid
(FC15) (MW=190) and ethyl coumarin-3-carboxylate (FC16)
(MW=218) were all obtained from Aldrich Chemical Co. Inc.
Milwaukee, USA. 6-Methoxy-(FC4) (MW=204) and 6-fluoro-3-
formylchromone (FC6) (MW=192) were synthesized as described in
the literature (12). The structures of these compounds are given in
Figure 1. Their log p-values have been reported elsewhere (10).
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Cell culture. Normal human gingival fibroblast (HGF), human pulp
cell (HPC) and human periodontal ligament fibroblast (HPLF)
were obtained from human periodontal tissue after informed
consent, according to the guideline of Meikai University Ethic
Committee (No. 0206). Since normal cells have a limited life-span,
cells at 3-7 population doubling levels (PDL) were used for the
present study. Human oral squamous cell carcinoma cell lines
(HSC-2, HSC-3) were supplied by Prof. Nagumo, Showa
University, and Dr. Fukuda, Meikai University, respectively.
Human submandibular gland carcinoma cell line (HSG) was
supplied by Drs. Atsumi and Kurihara, Meikai University. Human
promyelocytic leukemia cell line (HL-60) was supplied by Prof.
Nakaya, Showa University.
HL-60 cells were maintained at 37ÆC in RPMI-1640 medium
supplemented with 10% heat-inactivated FBS in a humidified 5%
CO2 atmosphere. Other cells were cultured as a monolayer culture
at 37ÆC in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 10% heat-inactivated fetal bovine serum (FBS)
in a humidified 5% CO2 atmosphere, and subcultured by
trypsinization. 
Cytotoxic activity. The relative viable cell number of adherent cells
was determined by MTT methods, while that of non-adherent cells
(HL-60 cells) was determined by trypan blue dye exclusion. 
For the MTT assay, the cells were treated for 24 h without
(control) or with different concentrations (1-1000 ÌM) of test
samples. The samples were dissolved in dimethyl sulfoxide
(DMSO) at 100 mM, and added to the medium after dilution with
the cuture medium. The final DMSO concentration was below 1%,
that did not significantly affect the cell growth. The cells were
washed once with phosphate-buffered saline without Mg2+ or Ca2+
and further incubated for 4 h with 0.2 mg/mL MTT in DMEM +
10% FBS. After removal of the medium, the cells were lysed with
0.1 mL of DMSO. The absorbance at 540 nm of the solubilized
formazan pellet (which reflects the relative viable cell number) was
then determined by microplate reader (Biochromatic Labsystem,
Helsinki, Finland). 
For the trypan blue dye exclusion assay, the number of cells
which did not incorporate the trypan blue dye was calculated as the
viable cell number by counting using a hemocytometer. From the
dose-response curve, the 50% cytotoxic concentration (CC50) was
determined (13). Tumor-specific cytotoxicity (SI value) was
determined by the following equation: SI=[CC50 (HGF + HPC +
HPLF)/CC50 (HSC-2 + HSC-3 + HSG + HL-60)] x 4/3.
Measurement of anti-H. pylori activity. The micro-dilution broth
method was used to determine the minimum inhibitory
concentration (MIC). Brain heart infusion (BHI) broth containing
10% FBS (Biofluid, Inc. Rockville, MD, USA) and 0.1% glucose
was used as the medium and was cultured in a jar conditioned with
AnaeroPack (Campylo)(Mitsubishi Gas Chemical Co., Inc.).
Briefly, H. pylori was inoculated in the medium and cultured at
37ÆC for 2 days. The collected bacterial suspension was diluted to
approximately 107 colony forming units (CFU)/mL with the
in vivo 21: 829-834 (2007)
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Figure 1. Chemical structures and calculated log p values of chromone (FC1-13) and coumarin (FC14-16) derivatives.
medium. The compounds were dissolved in DMSO and diluted
stepwise with the medium, and put them in a microplate reader.
To the solution of the compounds, a suspension of bacteria was
added to make 106 CFU/150 ÌL/well. The mixture was incubated
at 37ÆC for 5 days. The MIC values of the compounds were
determined from the dose-response curves. These values in Table
III represent the mean from duplicate determinations (13).
Measurement of urease. Jack bean urease was obtained from Sigma-
Aldrich Co. (St. Louis, MO, USA). The assay mixture, containing
25 ÌL (4U) of jack bean urease and 25 ÌL (100 Ìg) of the test
compound, was preincubated for 0.5 or 3 h at 25ÆC in a 96-well
assay plate. After preincubation, 0.2 mL of 100 mM phosphate
buffer pH 6.8 containing 500 mM urea and 0.002% phenol red
were added and incubated at room temperature. The reaction time,
required for enough ammonium carbonate to form to raise the pH
of the phosphate buffer from 6.8 to 7.7, was measured by micro
plate reader (570 nm) (14, 15). The IC50 values in Table III
represents the mean from duplicate determinations.
Assay for anti-HIV activity. Human T-cell leukemia virus-I (HTLV-
I)-bearing CD4-positive human T-cell lines (MT-4 cells) were
infected with HIV-1IIIB at a multiplicity of infection (m.o.i.) of
0.01. HIV- or mock-infected MT-4 cells (1.5x105/ÌL, 200 ÌL) were
placed into 96-well microtiter plates in RPMI-1640 medium
supplemented with 10% heat-inactivated fetal calf serum (FCS)
and incubated in the presence of different concentrations (5-fold
serial dilutions) of the compounds tested. The compounds FC1-16,
DS and CRDS were tested between 1000 to 0.0026 Ìg/mL
concentrations. Those of AZT and ddC were between 500 to
0.0013 ÌM and 5000 to 0.0128 ÌM, respectively. After incubation
for 5 days at 37ÆC in a CO2 incubator, the cell viability was
quantified by a colorimetric assay (at 540 nm and 690 nm),
monitoring the ability of viable cells to reduce 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to a
blue formazan product (16). All data represent the mean values of
triplicate measurements. The values are expresed as percentage
cytotoxicity and percentage antiviral protection, from which 50%
cytotoxic concentration (CC50) and 50% effective concentration
(EC50) are calculated. Thus, the selectivity index (SI) in Table II
was defined as follows: SI=CC50/EC50.
Results
Cytotoxic activity. The 6-substituted 3-formylchromone
derivatives (FC1-8) screened for their tumor-specific
cytotoxic potentials are shown in Figure 1. Their CC50
values for the four tumor cell lines and three normal cells
are summarized in Table I. Cytotoxic data for the related
chromone derivatives (FC9-13), coumarin derivatives
(FC14-16), doxorubicin and (–)-epigallocatechin-3-gallate
(EGCG) are also included in the Table. 
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Table I. Cytotoxic activity of 3-formylchromones and related compounds against normal and tumor cells.
Compound 50% Cytotoxic concentration (CC50, ÌM) SIa=
CC50 (normal)/ 
Human tumor cell lines Normal cells CC50 (tumor) 
HSC-2 HSC-3 HSG HL-60 HGF HPC HPLF 
FC1 89 225 332 59 552 322 678 2.9 
FC2 47 184 128 13 307 188 404 3.2 
FC3 42 172 95 20 171 102 235 2.1 
FC4 80 99 166 30 490 175 635 4.6 
CF5 84 262 546 78 750 521 679 2.7 
FC6 22 165 91 8 327 293 651 5.9 
FC7 46 73 92 17 166 74 208 2.6 
FC8 64 81 169 41 260 97 419 2.9 
FC9 42 102 115 30 173 86 159 1.9 
CF10 56 117 215 52 390 215 388 3.0 
FC11 75 131 216 40 246 193 276 2.1 
FC12 250 692 687 445 754 866 876 1.6 
FC13 784 679 >1000 853 >1000 >1000 >1000 ><1.2 
FC14 314 469 >1000 843 945 >1000 861 ><1.4 
CF15 786 763 966 951 801 887 824 1.0 
FC16 638 875 932 461 813 1000 844 1.2 
Doxorubicin 9 8 37 20 >1000 >1000 >1000 >54.1
EGCGb 215 375 496 83 >1000 >1000 >1000 >3.4 
Near confluent cells were incubated with or without different concentrations of each compound for 24 h and the relative viable cell number (absorbance
at 540 nm of the MTT-stained cell lysate) was determined by the MTT method. The viable cell number of HL-60 cells was determined by trypan blue
exclusion. The CC50 was determined from the dose-response curve. Each value represents the mean from duplicate determinations. aDetermined by the
equation: SI=[CC50(HGF + HPC + HPLF ) / CC50(HSC-2 + HSC-3 + HSG + HL-60)] x 4/3. bEGCG: (–)-Epigallocatechin-3-gallate. 
The average CC50 value of FC1 to HSC-2, HSC-3, HSG
and HL-60 cells was 176 ÌM towards these four cell lines.
6-Substituted 3-formylchromones (FC2-4 and 6-11), but 6-
nitro derivative (FC5), showed higher cytotoxicity than the
compound FC1, and 6-fluoro (FC6), 6-chloro (FC7) and 6-
chloro-7-methyl (FC9) derivatives were the most cytotoxic.
The cytotoxicity of FC12 and 13 was much less than that
of FC1-11, suggesting that the presence of 3-formyl group
was beneficial. In order to assess the preferential toxicity for
tumor cells, a selectivity index (SI) was calculated for each
compound. All 3-formylchromones (FC1-13) displayed
preferential toxicity for malignant cells and their SI values
were shown in Table I. Normal cells exhibited a higher
resistance to all of these compounds as compared with the
tumor cell lines, which resulted in an elevation of the SI
values of some derivatives. In particular, FC4 and 6 showed
excellent selectivity (SI=4.6 and 5.9, respectively).
Anti-HIV activity. The inhibition of HIV-induced cytopathic
effects by FC compounds was studied. However, there was no
significant inhibition by FC1-16 of the cytopathic effects of
HIV infection in MT-4 cells using effective concentrations of
>200 Ìg/mL (selectivity index (SI) <1), compared with four
positive controls-dextran sulfate (DS)(SI=56), curdlan sulfate
(CRDS)(SI=3392), AZT (SI=8726) and dideoxycytidine
(ddC)(SI=1433). The cytotoxic concentration (CC50) against
mock-infected MT-4 cells varied greatly (Table II); values of
FC3, 6, 7 or 9 were well fitted to their cytotoxic activity
against tumor cell lines (Table I). 
Anti-H. pylori activity. H. pylori is considered to be the major
causative agent of several gastric pathologies, such as chronic
gastritis, peptic ulcer and stomach cancer (17). Today,
control of this organism is an important goal of medicinal
science. As a result, there is a need to develop new
therapeutic agents with selective antibacterial activity against
H. pylori (18). As a part of a screening program of a number
of compounds, a series of chromone derivatives (FC1-16)
were screened against H. pylori and the MIC figures are
given in Table III. FC3, 7, 8 and 10 showed potent anti-H.
pylori activity. The anti-H. pylori activity of FC10 was the
most potent, equipotent to that of metronidazole. Thus, the
addition of Cl at the C8-position (FC10) increased anti-H.
pylori activity, suggesting that this position is important as
the electrophilic and lipophilic features. On the other hand,
interestingly, the addition of an extra bromine substituent at
position 8 (FC11) reduced the activity.
Urease inhibition activity. Ureases are sulfhydryl enzymes
which have a cysteine residue in the active site and catalyse
in vivo 21: 829-834 (2007)
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Table III. Urease inhibitory and anti-H. pylori activity of 3-formyl-
chromones and related compounds.
Compound ∞nti-H. pylori IC50 (Ìg/mL)a
MIC (Ìg/mL) 
0.5 h 3 h 
FC1 >100 >200 >200 
FC2 >100 >200 >200 
FC3 41 >200 >200 
FC4 >100 >200 >200 
FC5 100 >200b >200b
FC6 >100 >200 >200 
FC7 81 >200 >200 
FC8 75 >200 >200 
FC9 >100 >200 >200 
FC10 23 0.195 0.169 
FC11 >100 0.220 0.136 
FC12 >100 >200 >200 
FC13 >100 >200 >200 
FC14 >100 >200 >200 
FC15 >100 >200 >200 
FC16 >100 >200 >200 
Hydroxyurea (HU) - 0.016c 0.0074c 
Clarithromycin 0.022 - - 
Amoxicillin 0.16 - - 
Metronidazole 45d - - 
aIC50: 50% inhibitory concentration; bthe deep yellow color of the
solution of the sample interfered with the assay; cour previous data
(15); dour previous data (13). 
Table II. anti-HIV activity of 3-formylchromones and related compounds.
Compound CC50 (Ìg/mL) EC50 (Ìg/mL) SI 
[CC50/EC50] 
FC1 30.8 >40 <1 
FC2  39.8 >40 <1 
FC3 10.6 >40 <1 
FC4 96.7 >200 <1 
FC5 35.4 >40 <1 
FC6 17.0 >40 <1 
FC7 17.9 >40 <1 
FC8 28.1 >40 <1 
FC9 19.2 >40 <1 
FC10 87.8 >200 <1 
FC11 92.3 >200 <1 
FC12 121.9 >200 <1 
FC13 146.2 >200 <1 
FC14 395.5 >1000 <1 
FC15 612.9 >1000 <1 
FC16 439.9 >1000 <1 
DS 125.8 2.26 56 
CRDS 402.2 0.12 3392 
AZT(ÌM) 152.8 0.02 8726 
ddC(ÌM) 3459.7 2.41 1433 
DS: dextran-sulfate; CRDS: curdlan-sulfate; AZT: 3'-azido-3'- dideoxy-
thymidine; ddC: dideoxycytidine. 
the hydrolysis of urea (19). The enzymatic hydrolysis of urea
causes an abrupt increase in overall pH, which negatively
influences human health and agriculture. In particular,
urease activity constitutes a virulence factor in human
infections of the urinary and gastrointestinal tracts. H. pylori
produces a large amount of urease which is believed to play
an essential role in facilitating its survival. Urease inhibitors
have been regarded as targets for new anti-ulcer drugs (20).
A number of ·,‚-unsaturated ketones have been
demonstrated to show urease-inhibitory activities (21). FC10
and FC11 showed potent urease inhibitory activity.
However, FC1-4, 6-9 and 12-16 exhibited little or no ability
to inhibit urease (>200 Ìg/mL). The deep yellow color of
the solution of FC5 interfered with the assay. 
The anti-urease inhibitory potency of 6-chloro-(FC7) and
6-bromo-(FC8) compounds was much less in comparison with
6,8-dichloro-(FC10) and 6,8-dibromo-(FC11) compounds.
Therefore, including a weak electron-withdrawing group, such
as Cl or Br, at both C-6 and C-8 positions increased the
lipophilicity and the activity.
Discussion
We found that 3-formylchromones generally possess several
interesting biological activities which strongly depend on the
nature and position of substituents. The hydrophobicity of
an individual chromone is certainly not the only
determinant of its activity (10). The results showed that the
all 6-substituted 3-formylchromones, but not the 6-nitro-
substituted one (FC5), exhibit more potent cytotoxicity
against tumor cell lines as compared to the parent 3-
formylchromone (FC1). However, there was no clear-cut
relationship between the chemical structure of the
compounds tested and their cytotoxic activity. On the other
hand, only the compounds with two halogen groups at C-6
and C-8 positions exhibited urease inhibitory activity. Anti-
H. pylori activity is only shown by derivatives with Br group
at C-8 position. 
The concept of privileged structures or scaffolds was
emerged as one of the guiding principles of modern drug
discovery (2). Molecules with the chromone scaffold are
privileged substructures exhibiting a range of biological
activities (1, 4, 7, 10) and are present in large quantities in
human diets. In addition, chromones represent an
attractive source of medicinally interesting compounds due
to their low toxicity. 3-Formylchromones bearing an
electron-withdrawing formyl group at C-3 are highly
functional molecules, capable of reacting as Michael
acceptors. It seems reasonable, therefore, that the
exploration of more potent or better bioavailable agent
and cancer cell line-specific cytotoxic agent can be
achieved through further modifications of the 3-
formylchromone. 
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